1. Home
  2. DCTH vs GRRR Comparison

DCTH vs GRRR Comparison

Compare DCTH & GRRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • GRRR
  • Stock Information
  • Founded
  • DCTH 1988
  • GRRR 2001
  • Country
  • DCTH United States
  • GRRR United Kingdom
  • Employees
  • DCTH 76
  • GRRR N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • GRRR Computer Software: Prepackaged Software
  • Sector
  • DCTH Health Care
  • GRRR Technology
  • Exchange
  • DCTH Nasdaq
  • GRRR Nasdaq
  • Market Cap
  • DCTH 426.3M
  • GRRR 417.6M
  • IPO Year
  • DCTH N/A
  • GRRR N/A
  • Fundamental
  • Price
  • DCTH $11.52
  • GRRR $20.24
  • Analyst Decision
  • DCTH Strong Buy
  • GRRR Buy
  • Analyst Count
  • DCTH 4
  • GRRR 1
  • Target Price
  • DCTH $24.00
  • GRRR $18.00
  • AVG Volume (30 Days)
  • DCTH 850.4K
  • GRRR 3.5M
  • Earning Date
  • DCTH 08-04-2025
  • GRRR 06-18-2025
  • Dividend Yield
  • DCTH N/A
  • GRRR N/A
  • EPS Growth
  • DCTH N/A
  • GRRR N/A
  • EPS
  • DCTH N/A
  • GRRR N/A
  • Revenue
  • DCTH $53,850,000.00
  • GRRR $84,196,961.00
  • Revenue This Year
  • DCTH $155.42
  • GRRR $36.59
  • Revenue Next Year
  • DCTH $37.93
  • GRRR $30.68
  • P/E Ratio
  • DCTH N/A
  • GRRR N/A
  • Revenue Growth
  • DCTH 1068.87
  • GRRR 19.91
  • 52 Week Low
  • DCTH $7.17
  • GRRR $2.09
  • 52 Week High
  • DCTH $18.23
  • GRRR $44.15
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 32.83
  • GRRR 48.90
  • Support Level
  • DCTH $12.11
  • GRRR $20.08
  • Resistance Level
  • DCTH $14.15
  • GRRR $24.70
  • Average True Range (ATR)
  • DCTH 0.57
  • GRRR 2.33
  • MACD
  • DCTH -0.16
  • GRRR -0.10
  • Stochastic Oscillator
  • DCTH 9.67
  • GRRR 24.31

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About GRRR Gorilla Technology Group Inc.

Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.

Share on Social Networks: